My research areas include developmental biology, esophageal arresia, tracheoesophageal fistula and airway malacia. This work involves molecular developmental pathophysiology of abnormal tracheoesophageal development.
I’m also interested in innovative molecular treatments for abnormal or injured lung alveolization. My team and I look for the molecular machinery that regulates the first stages of respiratory and digestive organ development. In particular, we study the foregut progenitor cells in the ventral endoderm, which are the early building blocks of the liver, lungs and pancreas.
The questions my team and I are attempting to answer are:
I began my research interests after working with pregnant patients in neonatology fetal care. I was first inspired to be a healthcare provider and physician when I saw that this career could alter patient outcomes by enhancing early clinical trajectories.
The awards that I have been recognized for include:
My research has been published in notable journals, such as Developmental Cell, Cell Reports and Developmental Dynamics.
MD: University of Rochester School of Medicine and Dentistry, Rochester, NY, 2002.
PhD: Biology.
Residency: Golisano Children’s Hospital at Strong, University of Rochester, Rochester, NY, 2002-2005.
Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2005-2008.
Certifications: In Pediatrics, 2007 American Board of Pediatrics; American Board of Pediatrics, Board Eligible in Neonatal-Perinatal Medicine, 2008.
Neonatal care; neonatal lung disease; neonatal malformations and anomalies
Neonatology, Perinatal, Fetal Care
Lung progenitor development; stem cell differentiation; fetal malformations
Neonatology
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Formation and characterization of BMP2/GDF5 and BMP4/GDF5 heterodimers. BMC Biology. 2023; 21:16.
Demonstration of Safety in Wild Type Mice of npFOXF1, a Novel Nanoparticle-Based Gene Therapy for Alveolar Capillary Dysplasia with Misaligned Pulmonary Veins. Biologics: Targets and Therapy. 2023; 17:43-55.
Identification and validation of candidate risk genes in endocytic vesicular trafficking associated with esophageal atresia and tracheoesophageal fistulas. Human Genetics and Genomics Advances. 2022; 3:100107.
Endosome-Mediated Epithelial Remodeling Downstream of Hedgehog-Gli Is Required for Tracheoesophageal Separation. Developmental Cell. 2019; 51:665-674.e6.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey